$3.79
-0.08-2.07%
At close: Sep 1, 5:00 PM EST
$3.87
N/A
Pre-Market: 5:29 AM EST
C4 Therapeutics Inc
CCCCNASDAQ
C4 Therapeutics Earnings & Forecasts
C4 Therapeutics (CCCC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
C4 Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.25 | $-0.41 | $-0.42 |
| Actual | $-0.18 | $-0.20 | $-0.18 | $-0.44 |
| Surprise | +21.7% | +20.0% | +56.1% | -4.76% |
| Revenue | ||||
| Estimate | $4.4M | $4.8M | $4.6M | $6.4M |
| Actual | $6.6M | $6.2M | $11.0M | $11.2M |
| Surprise | +50.9% | +27.3% | +139.1% | +76.3% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.20 | $-0.23 |
| Revenue | ||
| Consensus | $5.8M | $4.8M |
